Drugplain

NOURIANZ 40 mg/1

istradefylline · TABLET, FILM COATED · Kyowa Kirin, Inc.

No Recall History
Plain English

NOURIANZ is a tablet, film coated containing istradefylline at 40 mg/1, taken oral. Manufactured by Kyowa Kirin, Inc..

Key Facts

Brand Name
NOURIANZ
Generic Name
istradefylline
NDC Code (Product)
42747-604
Manufacturer
Kyowa Kirin, Inc.
Strength
40 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA022075
Marketing Start
08/27/2019

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

death706 reports
drug ineffective624 reports
hallucination603 reports
dyskinesia479 reports
condition aggravated446 reports
dizziness419 reports
product dose omission issue359 reports
constipation353 reports
fall333 reports
tremor261 reports

Frequently Asked Questions

What is NOURIANZ used for?

NOURIANZ contains istradefylline. It is a tablet, film coated taken oral. Consult your doctor for specific uses.

Is NOURIANZ a controlled substance?

NOURIANZ is not classified as a controlled substance by the DEA.

What is the generic name for NOURIANZ?

The generic name for NOURIANZ is istradefylline. There are no other listed brand versions of istradefylline.

What is the NDC code for NOURIANZ 40 mg/1?

The NDC (National Drug Code) for NOURIANZ 40 mg/1 is 42747-604, listed by Kyowa Kirin, Inc..

Product NDC

42747-604

Package NDC

42747-604-07

Other NOURIANZ Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)